| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02328183 | Hospital Infection | Drug: Polymyxin B | Mahidol University | Phase 4 | 2014-12-01 | 2015-08-31 |
| NCT01429701 | Eczema | Drug: polymyxin B sulphate + prednisolone + benzocaine + clioquinol|Drug: betamethasone + gentamicin + tolnaftato + cleoquinol | EMS | Phase 3 | 2012-05-01 | 2013-03-01 |
| NCT00490477 | Gram-Negative Bacterial Infections|Sepsis | Device: Polymyxin -B fiber hemoperfusion system | University of Turin, Italy | Phase 3 | 2006-05-01 | 2010-06-04 |
| NCT01646229 | Abdominal Sepsis|Peritonitis|Colon Perforation | Other: Polymyxin-B hemoperfusion|Other: Control | University Hospital, Geneva | | 2012-01-01 | 2016-05-11 |
| NCT02682355 | Pneumonia|Blood Stream Infection | University of Michigan | | 2016-02-01 | 2017-03-21 |
| NCT02413541 | Severe Sepsis | Procedure: Polymyxin-B Hemoperfusion|Procedure: Standard treatment | Chulalongkorn University | | 2015-01-01 | 2016-01-26 |
| NCT02134106 | Bacteremia|Healthcare-associated Pneumonia|Ventilator-associated Pneumonia | Drug: Polymyxin B|Drug: Polymyxin B + Doripenem | Tan Tock Seng Hospital|Singapore General Hospital|National University Hospital, Singapore|Changi General Hospital | Phase 2|Phase 3 | 2015-01-01 | 2014-12-12 |
| NCT02871024 | Sepsis | Device: Toraymyxin | National Taiwan University Hospital | Phase 2 | 2016-08-01 | 2016-08-17 |
| NCT00534391 | Hordeolum | Drug: neomycin sulfate, polymyxin B sulfate and gramicidin|Drug: Artificial tear | Chulalongkorn University | Phase 3 | 2007-09-01 | 2010-11-22 |
| NCT00629382 | Gram-Negative Bacterial Infections|Sepsis|Septic Shock | Device: Polymyxin B immobilized fiber column|Other: Conventional medical therapy in the ICU | St. Bortolo Hospital | Phase 4 | 2004-12-01 | 2008-12-01 |
| NCT01948778 | Patients in Septic Shock | Device: oXiris filter|Device: Toraymyxin Filter|Device: Standard of Care | University of Zurich | | 2013-08-01 | 2015-02-24 |
| NCT01227863 | Bacterial Conjunctivitis|Acute | Drug: MAXINOM|Drug: Maxitrol | Azidus Brasil | Phase 3 | 2011-02-01 | 2010-10-22 |
| NCT01222663 | Peritonitis|Septic Shock | Device: standard therapy|Device: hemoperfusion | Meditor SAS | Phase 3 | 2010-10-01 | 2013-12-17 |
| NCT02825329 | Septic Shock|Endotoxemia | Device: TORAYMYXIN PMX-20R | Spectral Diagnostics (US) Inc. | | | 2016-07-04 |
| NCT01046669 | Septic Shock|Endotoxemia | Device: TORAYMYXIN PMX-20R (PMX cartridge) | Spectral Diagnostics (US) Inc. | Phase 3 | 2010-06-01 | 2016-10-14 |
| NCT02641236 | Hematopoietic Stem Cell Transplantation (HSCT)|Acute GVH Disease | Drug: Vancomycin-polymyxin B | Dana-Farber Cancer Institute | Phase 2 | 2016-03-01 | 2016-08-11 |
| NCT02186457 | Surgery|Infection | Drug: Polymyxin B in Normal Saline|Other: Placebo: Normal Saline | Indiana University | | 2014-11-01 | 2017-03-05 |
| NCT01756755 | Sepsis | Device: PMX-20R Hemoperfusion | National Taiwan University Hospital | Phase 4 | 2012-12-01 | 2015-02-04 |
| NCT02582255 | Poliomyelitis | Biological: Sabin mOPV2 | Fidec Corporation|Bill and Melinda Gates Foundation | Phase 4 | 2015-11-01 | 2015-10-19 |
| NCT00000635 | Herpes Simplex|HIV Infections | Drug: Trifluridine|Drug: Bacitracin zinc/Polymyxin B sulfate | National Institute of Allergy and Infectious Diseases (NIAID)|Glaxo Wellcome | | | 2012-03-29 |
| NCT02515656 | Vaginitis | Drug: POLYGYNAX|Drug: GYNODAKTARIN|Drug: Placebo | Laboratoire Innotech International|International Clinical Trials Association|Venn Life Sciences | Phase 3 | 2015-09-01 | 2016-10-18 |
| NCT00997139 | Nasal Carriers of Staphylococcus Aureus | Drug: Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg) | Northwestern University | | 2009-09-01 | 2014-12-11 |
| NCT01584271 | Acute Otitis Externa | Device: Natural Ear Comfort(TM), a botanical ear drops product | Assuta Hospital Systems | Phase 2 | 2011-07-01 | 2013-07-07 |
| NCT02344732 | Corneal Diseases | Drug: Dexamethasone 0.1%, Neomycin Sulfate and Polymyxin B Sulfate topical eye drops four times daily|Drug: Homatropine 2% eye drops thrice daily|Drug: Oxygen gas | University of Science Malaysia | | 2013-10-01 | 2015-01-22 |
| NCT01431170 | Congenital Nasolacrimal Duct Obstruction | Drug: Besivance Treatment Group|Drug: Polytrim Treatment Group | Rutgers, The State University of New Jersey|Bausch & Lomb Incorporated | Phase 1 | 2011-09-01 | 2016-06-15 |
